Steering a course through the COVID-19 pandemic: should the SECURE-IBD registry influence prescribing for patients with inflammatory bowel disease?

Catarina Frias Gomes; Thomas Chapman; Jack Satsangi; Joana Torres

doi:10.1053/j.gastro.2021.01.216

Steering a course through the COVID-19 pandemic: should the SECURE-IBD registry influence prescribing for patients with inflammatory bowel disease?

Catarina Frias Gomes
, Thomas Chapman
, Jack Satsangi
, Joana Torres

Research output: Contribution to journal › Comment/debate

1 Citation (Scopus)

Original language	English
Pages (from-to)	1867-1870
Number of pages	4
Journal	Gastroenterology
Volume	160
Issue number	5
DOIs	https://doi.org/10.1053/j.gastro.2021.01.216
Publication status	Published - Apr 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1053/j.gastro.2021.01.216

Cite this

@article{2f1c87f0a24c4496a3cfa534f6bc562c,

title = "Steering a course through the COVID-19 pandemic: should the SECURE-IBD registry influence prescribing for patients with inflammatory bowel disease?",

author = "Gomes, \{Catarina Frias\} and Thomas Chapman and Jack Satsangi and Joana Torres",

year = "2021",

month = apr,

doi = "10.1053/j.gastro.2021.01.216",

language = "English",

volume = "160",

pages = "1867--1870",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "W.B. Saunders",

number = "5",

}

TY - JOUR

T1 - Steering a course through the COVID-19 pandemic

T2 - should the SECURE-IBD registry influence prescribing for patients with inflammatory bowel disease?

AU - Gomes, Catarina Frias

AU - Chapman, Thomas

AU - Satsangi, Jack

AU - Torres, Joana

PY - 2021/4

Y1 - 2021/4

UR - https://www.scopus.com/pages/publications/85102000102

U2 - 10.1053/j.gastro.2021.01.216

DO - 10.1053/j.gastro.2021.01.216

M3 - Comment/debate

C2 - 33516701

AN - SCOPUS:85102000102

SN - 0016-5085

VL - 160

SP - 1867

EP - 1870

JO - Gastroenterology

JF - Gastroenterology

IS - 5

ER -

Steering a course through the COVID-19 pandemic: should the SECURE-IBD registry influence prescribing for patients with inflammatory bowel disease?

UN SDGs

Access to Document

Other files and links

Cite this